Role of renal biomarkers as predictors of acute kidney injury in cardiac surgery

Asian Cardiovascular and Thoracic Annals

Volumn 22, Issue 2, 2014, Pages 234-241

  Ghatanatti, Ravi ^a   Teli, Anita ^b   Tirkey, Sundeep Sanjivan ^a   Bhattacharya, Subhankar ^a   Sengupta, Gautam ^a   Mondal, Ansuman ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b BLDE UNIVERSITY   (India)

Author keywords

acute kidney injury; biological markers; cardiac surgical procedures; postoperative complications; predictive value of tests

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN C; FATTY ACID BINDING PROTEIN; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TETRAHYDROBIOPTERIN;

ACUTE KIDNEY FAILURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIAGNOSTIC TEST ACCURACY STUDY; HEART SURGERY; HUMAN; REVIEW; SENSITIVITY AND SPECIFICITY; UREA BLOOD LEVEL;

ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS;

ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; EARLY DIAGNOSIS; HUMANS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84892908166     PISSN: 02184923     EISSN: 18165370     Source Type: Journal    
DOI: 10.1177/0218492313502028     Document Type: Review

References (70)

1. Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004 ; 15: 1597-1605
2. Loef BG, Epema AH, Smilde TD, et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol. 2005 ; 16: 195-200
3. Parker RA, Himmelfarb J, Tolkoff-Rubin N, Chandran P, Wingard RL, Hakim RM. Prognosis of patients with acute renal failure requiring dialysis: results of a multicenter study. Am J Kidney Dis. 1998 ; 32: 432-443
4. Bagshaw SM, George C, Dinu I, Bellomo R. A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Tranplant. 2008 ; 23: 1203-1210
5. Ostermann M, Chang RW. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med. 2007 ; 35: 1837-1843
6. Parikh CR, Devarajan P. New biomarkers of acute kidney injury. Crit Care Med. 2008 ; 36: S159 - S165
7. Moore E, Bellomo R, Nichol A. Biomarkers of acute kidney injury in anesthesia, intensive care and major surgery: from the bench to clinical research to clinical practice [Review]. Minerva Anesthesiol. 2010 ; 76: 425-440
8. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004 ; 8: R204 - R212
9. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007 ; 11: R31 - R31
10. Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int. 2008 ; 73: 538-546
11. Joannidis M, Metnitz B, Bauer P, et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med. 2009 ; 35: 1692-1702
12. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent induced reductions in renal function by acetylcysteine. N Engl J Med. 2000 ; 343: 180-184
13. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography related renal tissue injury (the APART trial). Am J Cardiol. 2002 ; 89: 356-358
14. Rahman SN, Kim GE, Mathew AS, et al. Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int. 1994 ; 45: 1731-1738
15. Franklin SC, Moulton M, Sicard GA, Hammerman MR, Miller SB. Insulin-like growth factor I preserves renal function postoperatively. Am J Physiol. 1997 ; 272: F257 - F2579
16. Haase M, Haase-Fielitz A, Bellomo R, et al. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double blind, randomized control trial. Crit Care Med. 2009 ; 37: 39-47
17. Gonzales DA, Norsworthy KJ, Kern SJ, et al. A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity. BMC Med. 2007 ; 5: 32-32
18. Nigwekar SU, Kandula P. N-acetylcysteine in cardiovascular-surgery- associated renal failure: a meta-analysis [Review]. Ann Thorac Surg. 2009 ; 87: 139-147
19. Koyner JL, Vaidya VS, Bennett MR, et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol. 2010 ; 5: 2154-2165
20. Pépin MN, Bouchard J, Legault L, Ethier J. Diagnostic performance of fractional excretion of urea and fractional excretion of sodium in the evaluations of patients with acute kidney injury with or without diuretic treatment. Am J Kidney Dis. 2007 ; 50: 566-573
21. Yavuz I, Asgun FH, Bolcal C, Bingol H, et al. Importance of urinary measurement of glutathione S-transferase in renal dysfunction patients after on- and off-pump coronary artery bypass surgery. Thorac Cardiovasc Surg. 2009 ; 57: 125-129
22. Zhou H, Hewitt SM, Yuen PS, Star RA. Acute kidney injury biomarkers - needs, present status, and future promise. Nephrol Self Assess Program. 2006 ; 5: 63-71
23. Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003 ; 14: 2534-2543
24. Mishra J, Mori K, Ma Q, et al. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol. 2004 ; 24: 307-315
25. Kell DB. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Medical Genomics. 2009 ; 2: 2-2
26. Schmidt-Ott KM, Mori K, Li JY, et al. Dual action of neutrophil gelatinase- associated lipocolin. J Am Soc Nephrol. 2007 ; 18: 407-413
27. Nickolas TL, O'Rourke MJ, Yang J, et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med. 2008 ; 148: 810-819
28. Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT. Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. Am J Kidney Dis. 2008 ; 52: 425-433
29. Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia reperfusion injury. J Clin Invest. 2005 ; 115: 610-621
30. Haase M, Bellomo R, Devarajan P, et al. Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults. Ann Thorac Surg. 2009 ; 88: 124-130
31. Haase-Fielitz A, Bellomo R, Devarajan P, et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery - a prospective cohort study. Crit Care Med. 2009 ; 37: 553-560
32. Tuladhar SM, Puntmann VO, Soni M, Punjabi PP, Bogle RG. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J Cardiovasc Pharmacol. 2009 ; 53: 261-266
33. Xin C, Yulong X, Yu C, Changchun C, Feng Z, Xinwei M. Urine neutrophil gelatinase-associated lipocalin and interleukin-18 predict acute kidney injury after cardiac surgery. Ren Fail. 2008 ; 30: 904-913
34. Haase-Fielitz A, Bellomo R, Devarajan P, et al. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transplant. 2009 ; 24: 3349-3354
35. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005 ; 365: 1231-1238
36. Wong CK, Ho CY, Li EK, Tam LS, Lam CW. Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematous. Clin Exp Immunol. 2002 ; 130: 345-351
37. Parikh CR, Jani A, Mishra J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006 ; 6: 1639-1645
38. Washburn KK, Zappitelli M, Arikan AA, et al. Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children. Nephrol Dial Transplant. 2008 ; 23: 566-752
39. Parikh CR, Mishra J, Thiessen-Philbrook H, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2006 ; 70: 199-203
40. Haase M, Bellomo R, Story D, Davenport P, Haase-Fielitz A. Urinary interleukin-18 does not predict acute kidney injury after adult cardiac surgery: a prospective observational cohort study. Crit Care. 2008 ; 12: R96 - R96
41. Barrett AJ, Davies ME, Grubb A. The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Commun. 1984 ; 120: 631-636
42. Zhang Z, Lu B, Sheng X, Jin N. Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis [Review]. Am J Kidney Dis. 2011 ; 58: 356-365
43. Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004 ; 65: 1416-1421
44. Herget-Rosenthal S, Marggraf G, Husing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004 ; 66: 1115-1122
45. Herget-Rosenthal S, Poppen D, Husing J, et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem. 2004 ; 50: 552-558
46. Ahlström A, Tallgren M, Peltonen S, Pettilä V. Evolution and predictive power of serum cystatin C in acute renal failure. Clin Nephrol. 2004 ; 62: 344-350
47. Mazul-Sunko B, Zarkovic N, Vrkic N, et al. Proatrial natriuretic peptide (1-98), but not cystatin C is predictive for occurrence of acute renal insufficiency in critically ill septic patients. Nephron. 2004 ; 97: c103 - c107
48. Villa P, Jimenez M, Soriano MC, Manzanares J, Casasnovas P. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care. 2005 ; 9: R139 - R143
49. Herrero-Morin JD, Malaga S, Fernandez N, et al. Cystatin C and beta2- microglobulin: markers of glomerular filtration in critically ill children. Crit Care. 2007 ; 11: R59 - R59
50. Delanaye P, Lambermont B, Chapelle JP, Gielen J, Gerard P, Rorive G. Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care unit. Intensive Care Med. 2004 ; 30: 982-983
51. Portilla D, Dent C, Sugaya T, et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2008 ; 73: 465-472
52. Nakamura T, Sugaya T, Node K, Ueda Y, Koide H. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis. 2006 ; 47: 439-444
53. Noiri E, Doi K, Negishi K, et al. Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury [Review]. Am J Physiol Renal Physiol. 2009 ; 296: 669-679
54. Doi K, Noiri E, Maeda-Mamiya R, et al. Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury. Crit Care Med. 2010 ; 38: 2037-2042
55. Negishi K, Noiri E, Sugaya T, et al. A role of liver fatty acid-binding protein in cisplatin-induced acute renal failure. Kidney Int. 2007 ; 72: 348-358
56. Yamamoto T, Noiri E, Ono Y, et al. Renal L-type fatty acid-binding protein in acute ischemic injury. J Am Soc Nephrol. 2007 ; 18: 2894-2902
57. Ferguson MA, Vaidya VS, Waikar SS, et al. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int. 2010 ; 77: 708-714
58. Negishi K, Noiri E, Maeda R, Portilla D, Sugaya T, Fujita T. Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin induced acute kidney injury. Kidney Int. 2008 ; 73: 1374-1384
59. Ichimura T, Bonventre JV, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up regulated in renal cells after injury. J Biol Chem. 1998 ; 273: 4135-4142
60. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre J. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002 ; 62: 237-244
61. Huo W, Zhang K, Nie Z, Li Q, Jin F. Kidney injury molecule-1 (KIM-1): a novel kidney-specific injury molecule playing potential double-edged functions in kidney injury [Review]. Transplant Rev (Orlando). 2010 ; 24: 143-146
62. Han WK, Waikar SS, Johnson A, et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008 ; 73: 863-869
63. Han WK, Wagener G, Zhu Y, Wang S, Lee HT. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol. 2009 ; 4: 873-882
64. Vaidya VS, Waikar SS, Ferguson MA, et al. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008 ; 1: 200-208
65. Westhuyzen J, Endre ZH, Reece G, et al. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant. 2003 ; 18: 543-551
66. Liangos O, Tighiouart H, Perianayagam MC, et al. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers. 2009 ; 14: 423-431
67. Endre ZH, Pickering JW, Walker RJ, et al. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int. 2011 ; 79: 1119-1130
68. Endre ZH, Pickering JW. New markers of acute kidney injury: giant leaps and baby steps. Clin Biochem Rev. 2011 ; 32: 121-124
69. Sucher R, Gehwolf P, Oberhuber R, et al. Tetrahydrobiopterin protects the kidney from ischemia-reperfusion injury. Kidney Int. 2010 ; 77: 681-689
70. Bonventre JV, Vaidya VS, Schmouder R, Feig P, Dieterle F. Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol. 2010 ; 28: 436-440